Yang et al., 2020 - Google Patents
O-GlcNAc transferase inhibits visceral fat lipolysis and promotes diet-induced obesityYang et al., 2020
View HTML- Document ID
- 18011743059878622479
- Author
- Yang Y
- Fu M
- Li M
- Zhang K
- Zhang B
- Wang S
- Liu Y
- Ni W
- Ong Q
- Mi J
- Yang X
- Publication year
- Publication venue
- Nature communications
External Links
Snippet
Excessive visceral fat accumulation is a primary risk factor for metabolically unhealthy obesity and related diseases. The visceral fat is highly susceptible to the availability of external nutrients. Nutrient flux into the hexosamine biosynthetic pathway leads to protein …
- 108010077991 O-GlcNAc transferase 0 title abstract description 192
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
- G01N33/502—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
- C12N15/113—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing
- C12N15/1137—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing against enzymes
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Yang et al. | O-GlcNAc transferase inhibits visceral fat lipolysis and promotes diet-induced obesity | |
Gan et al. | LATS suppresses mTORC1 activity to directly coordinate Hippo and mTORC1 pathways in growth control | |
Péterfy et al. | Insulin-stimulated interaction with 14-3-3 promotes cytoplasmic localization of lipin-1 in adipocytes | |
Svegliati et al. | Platelet-derived growth factor and reactive oxygen species (ROS) regulate Ras protein levels in primary human fibroblasts via ERK1/2: amplification of ROS and Ras in systemic sclerosis fibroblasts | |
Hsi et al. | Opposing effects of 15-lipoxygenase-1 and-2 metabolites on MAPK signaling in prostate: alteration in peroxisome proliferator-activated receptor γ | |
Hsi et al. | 15-Lipoxygenase-1 metabolites down-regulate peroxisome proliferator-activated receptor γ via the MAPK signaling pathway | |
Chen et al. | Interaction of Akt-phosphorylated ataxin-1 with 14-3-3 mediates neurodegeneration in spinocerebellar ataxia type 1 | |
Armstrong et al. | Regulation of endoplasmic reticulum stress-induced cell death by ATF4 in neuroectodermal tumor cells | |
Khaled et al. | Glycogen synthase kinase 3β is activated by cAMP and plays an active role in the regulation of melanogenesis | |
Ishida et al. | Induction of the cyclin-dependent kinase inhibitor p21Sdi1/Cip1/Waf1 by nitric oxide-generating vasodilator in vascular smooth muscle cells | |
Bilton et al. | Arrest-defective-1 protein, an acetyltransferase, does not alter stability of hypoxia-inducible factor (HIF)-1α and is not induced by hypoxia or HIF | |
Yin et al. | Dual-specificity tyrosine phosphorylation-regulated kinase 1A (Dyrk1A) modulates serine/arginine-rich protein 55 (SRp55)-promoted Tau exon 10 inclusion | |
Morishima et al. | CHIP deletion reveals functional redundancy of E3 ligases in promoting degradation of both signaling proteins and expanded glutamine proteins | |
Mineo et al. | Physical association with ras enhances activation of membrane-bound raf (RafCAAX) | |
Jiang et al. | Ras Mediates the Activation of Phospholipase D by v-Src (∗) | |
Kim et al. | Lysophosphatidic acid increases mesangial cell proliferation in models of diabetic nephropathy via Rac1/MAPK/KLF5 signaling | |
Nemazanyy et al. | Class III PI3K regulates organismal glucose homeostasis by providing negative feedback on hepatic insulin signalling | |
Caruano-Yzermans et al. | Mechanisms of the copper-dependent turnover of the copper chaperone for superoxide dismutase | |
Yu et al. | The scaffolding adapter Gab2, via Shp-2, regulates kit-evoked mast cell proliferation by activating the Rac/JNK pathway | |
Kukekov et al. | Direct interaction of the molecular scaffolds POSH and JIP is required for apoptotic activation of JNKs | |
Rao et al. | Chronic treatment of rats with sodium valproate downregulates frontal cortex NF‐κB DNA binding activity and COX‐2 mRNA 1 | |
Rybin et al. | Protein kinase D1 autophosphorylation via distinct mechanisms at Ser744/Ser748 and Ser916 | |
Yu et al. | Modulation of fatty acid synthase degradation by concerted action of p38 MAP kinase, E3 ligase COP1, and SH2-tyrosine phosphatase Shp2 | |
Richard et al. | Pyruvate dehydrogenase complex (PDC) subunits moonlight as interaction partners of phosphorylated STAT5 in adipocytes and adipose tissue | |
d'Angelo et al. | Cyclosporin A prevents the hypoxic adaptation by activating hypoxia-inducible factor-1α Pro-564 hydroxylation |